Items Per Page 102550 Year All202620252024202320222021202020192018201720162015201420132012201120102009 April 6, 2026 Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma PDF Version April 1, 2026 Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting PDF Version March 3, 2026 Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology PDF Version February 26, 2026 Delcath Systems Reports Fourth Quarter and Full Year 2025 Results PDF Version February 12, 2026 Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call PDF Version January 27, 2026 Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference PDF Version January 21, 2026 Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version January 9, 2026 Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results PDF Version
April 6, 2026 Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma PDF Version
April 1, 2026 Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting PDF Version
March 3, 2026 Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology PDF Version
February 12, 2026 Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call PDF Version
January 27, 2026 Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference PDF Version
January 21, 2026 Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
January 9, 2026 Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results PDF Version
